Prescription drug advertising comparing generic drugs or biological products and brand name drugs or biological products is subject to the §554.054 of the Act and in compliance with federal law.

Source Note: The provisions of this §309.8 adopted to be effective June 1, 2002, 27 TexReg 1782; amended to be effective December 6, 2015, 40 TexReg 8790